Development of genomic reference materials for cystic fibrosis genetic testing

Journal of Molecular Diagnostics

Volumn 11, Issue 3, 2009, Pages 186-193

  Pratt, Victoria M ^a,h   Caggana, Michele ^b   Bridges, Christina ^c   Buller, Arlene M ^a   DiAntonio, Lisa ^b   Highsmith, W Edward ^d   Holtegaard, Leonard M ^d   Muralidharan, Kasinathan ^a   Rohlfs, Elizabeth M ^e   Tarleton, Jack ^c   Toji, Lorraine ^f   Barker, Shannon D ^g   Kalman, Lisa V ^g  

^a QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^b WADSWORTH CENTER   (United States)

^c Fullerton Genetics Center   (United States)

^d MAYO CLINIC   (United States)

^e GENZYME CORPORATION   (United States)

^f Laboratory of Molecular and Cellular Biology of Hematopoiesis   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA;

ARTICLE; CELL LINE; CONTROLLED STUDY; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DNA DETERMINATION; DNA SEQUENCE; GENE FREQUENCY; GENE MUTATION; GENETIC ANALYSIS; GENOMICS; HUMAN; HUMAN CELL; LABORATORY; NUCLEOTIDE SEQUENCE; QUALITY CONTROL; ALLELE; GENETIC SCREENING; GENETICS; HUMAN GENOME; METHODOLOGY; SENSITIVITY AND SPECIFICITY; STANDARD;

ALLELES; CELL LINE; CYSTIC FIBROSIS; GENETIC SCREENING; GENOME, HUMAN; HUMANS; LABORATORIES; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY;

EID: 67149128742     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.2353/jmoldx.2009.080149     Document Type: Article

References (27)

1. Grody WW, Cutting GR, Klinger KW, Richards CS, Watson MS, Desnick RJ: Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 2001, 3:149-154
2. Committee on Genetics, American College of Obstetricians and Gynecologists: ACOG committee opinion. Number 325, December 2005. Update on carrier screening for cystic fibrosis. Obstet Gynecol 2005, 106:1465-1468
3. Watson MS, Cutting GR, Desnick RJ, Driscoll DA, Klinger K, Mennuti M, Palomaki GE, Popovich BW, Pratt VM, Rohlfs EM, Strom CM, Richards CS, Witt DR, Grody WW: Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panel. Genet Med 2004, 6:387-391
4. American College of Medical Genetics' Newborn Screening Expert Group: toward a uniform screening panel and system. Genet Med 2006, 8 Suppl 1:1S-252S
5. Grody WW, Cutting GR, Watson MS: The cystic fibrosis mutation "arms race": when less is more. Genet Med 2007, 9:739-744
6. Amos J, Feldman GL, Grody WW, Monaghan K, Palomaki GE, Prior TW, Richards CS, Watson MS: Technical Standards and Guidelines for CFTR Mutation Testing. American College of Medical Genetics 2006, pp1-28
7. Association for Molecular Pathology: Recommendations for in-house development and operation of molecular diagnostic tests. Am J Clin Pathol 1999, 111:449-463
8. Chen B, O'Connell CD, Boone DJ, Amos JA, Beck JC, Chan MM, Farkas DH, Lebo RV, Richards CS, Roa BB, Silverman LM, Barton DE, Bejjani BA, Belloni DR, Bernacki SH, Caggana M, Charache P, Dequeker E, Ferreira-Gonzalez A, Friedman KJ, Greene CL, Grody WW, Highsmith WE Jr., Hinkel CS, Kalman LV, Lubin IM, Lyon E, Payne DA, Pratt VM, Rohlfs E, Rundell CA, Schneider E, Willey AM, Williams LO, Willey JC, Winn-Deen ES, Wolff DJ: Developing a sustainable process to provide quality control materials for genetic testing. Genet Med 2005, 7:534-549
9. Code of Federal Regulations. The clinical laboratory improvement amendments (CLIA) 2007, 42 CFR Part 493
10. MM01-A2 Molecular diagnostic methods for genetic diseases-approved guideline. The clinical and laboratory standards institute (CLSI). 2nd ed. Wayne PA, CLSI, 2006
11. Potter NT, Spector EB, Prior TW: Technical standards and guidelines for Huntington disease. Genet Med 2004, 6:61-65
12. Williams LO, Cole EC, Lubin IM, Iglesias NI, Jordan RL, Elliott LE: Quality assurance in human molecular genetics testing-Status and recommendations. Arch Pathol Lab Med 2003, 127:1353-1358
13. Beck JC, Beiswanger CM, John EM, Satraiano, West D: Successful transformation of cryopreserved lymphocytes: a resource for epidemiological studies. Cancer Epidemiol Biomarkers Prev 2001, 10:551-554
14. Bernacki SH, Stankovic AK, Williams LO, Beck JC, Herndon JE, Snow-Bailey K, Prior TW, Matteson KJ, Wasserman LM, Cole EC, Stenzel TT: Establishment of stably EBV-transformed cell lines from residual clinical blood samples for use in performance evaluation and quality assurance in molecular genetic testing. J Mol Diagn 2003, 5:227-230
15. Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988, 16:1215
16. Strom CM, Janeszco R, Quan F, Wang S, Buller A, McGinness M, Sun W: Technical validation of a Tm biosciences luminex-based multiplex assay for detecting the American College of Medical Genetics-recommended cystic fibrosis mutation panel. J Mol Diagn 2006, 8:371-375
17. Hadd AG, Laosinchai-Wolf W, Novak CR, Badgett MR, Isgur LA, Goldrick M, WalkerPeach CR: Microsphere bead arrays and sequence validation of 5/7/9T genotypes for multiplex screening of cystic fibrosis polymorphisms. J Mol Diagn 2004, 6:348-355
18. Johnson MA, Yoshitomi MJ, Richards CS: A comparative study of five technologically diverse CFTR testing platforms. J Mol Diagn 2007, 9:401-407
19. Brinson EC, Adriana T, Bloch W, Brown CL, Chang CC, Chen J, Eggerding FA, Grossman PD, Iovannisci DA, Madonik AM, Sherman DG, Tam RW, Winn-Deen ES, Woo SL, Fung S: Introduction to PCR/ OLA/SCS, a multiplex DNA test, and its application to cystic fibrosis. Genet Test 1997, 1:61-68
20. Strom CM, Huang D, Chen C, Buller A, Peng M, Quan F, Redman J, Sun W: Extensive sequencing of the cystic fibrosis transmembrane regulator gene: assay validation and unexpected benefits of developing a comprehensive test. Genet Med 2003, 5:9-14
21. Heim RA, Sugarman EA, Allitto BA: Improved detection of cystic fibrosis mutations in the heterogeneous U.S. population using an expanded, pan-ethnic mutation panel. Genet Med 2001, 3:168-176
22. Monaghan KG, Feldman GL, Barbarotto GM, Manji S, Desai TK, Snow K: Frequency and clinical significance of the S1235R mutation in the cystic fibrosis transmembrane conductance regulator gene: results from a collaborative study. Am J Med Genet 2000, 95:361-365
23. Bernacki SH, Beck JC, Stankovic AK, Williams LO, Amos J, Snow-Bailey K, Farkas DH, Friez MJ, Hantash FM, Matteson KJ, Monaghan KG, Muralidharan K, Pratt VM, Prior TW, Richie KL, Levin BC, Rohlfs EM, Schaefer FV, Shrimpton AE, Spector EB, Stolle CA, Strom CM, Thibodeau SN, Cole EC, Goodman BK, Stenzel TT: Genetically characterized positive control cell lines derived from residual clinical blood samples. Clin Chem 2005, 51:2013-2024
24. Chatterjee R: Cases of mistaken identity. Science 2007, 315:928-931
25. Hughes P, Marshall D, Reid Y: Parkes H. Gelber C: the costs of using unauthenticated, over-passaged cell lines: how much more data do we need? Biotechniques 2007, 43:575-584
26. Amos Wilson J, Zoccoli MA, Jacobson JW, Kalman L, Krunic N, Matthijs G, Pratt VM, Schoonmaker MM, Tezak Z: Verification and validation of multiplex nucleic acid assays; approved guideline. MM17-A 2008, 28(9)
27. Christensen TM, Jama M, Ponek V, Lyon E, Wilson JA, Hoffmann ML, Bejjani BA: Design, development, validation, and use of synthetic nucleic acid controls for diagnostic purposes and application to cystic fibrosis testing. J Mol Diagn 2007, 9:315-319